Safety and efficacy of oral ciprofloxacin for the treatment of febrile neutropenia

被引：0
|
作者：
Sano, T. [1 ]
Makino, Y. [1 ]
Yokote, N. [1 ]
Hayashi, Y. [1 ]
机构：
[1] Natl Canc Ctr, Tokyo, Japan
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2013年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S88 / S88
页数：1
相关论文
共 50 条
  • [21] Prevention and treatment of febrile neutropenia
    Weissinger, F.
    Heinz, W. J.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2012, 5 (01) : 30 - 34
  • [22] Prevention and treatment of febrile neutropenia
    F. Weissinger
    W. J. Heinz
    memo - Magazine of European Medical Oncology, 2012, 5 (1) : 30 - 34
  • [23] TREATMENT OF SEVERE FEBRILE NEUTROPENIA
    MEURET, G
    ROUX, A
    HEIM, ME
    WESTERHAUSEN, M
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1980, 105 (51) : 1776 - 1779
  • [24] Prevention and treatment of febrile neutropenia
    Montemurro, F
    Gallicchio, M
    Aglietta, M
    TUMORI JOURNAL, 1997, 83 (02): : S15 - S19
  • [25] Treatment of febrile neutropenia at home
    Herbrecht, R
    EUROCANCER 96 - PROCEEDINGS OF THE NINTH CONGRESS, 1996, : 323 - 324
  • [26] EFFICACY AND SAFETY OF ORAL CIPROFLOXACIN IN THE TREATMENT OF RESPIRATORY-TRACT INFECTIONS ASSOCIATED WITH CHRONIC HEPATITIS
    ESPOSITO, S
    GALANTE, D
    BIANCHI, W
    GAGLIARDI, R
    AMERICAN JOURNAL OF MEDICINE, 1987, 82 (4A): : 211 - 214
  • [27] PROSPECTIVE-STUDY OF THE EFFICACY AND SAFETY OF ORAL AND INTRAVENOUS CIPROFLOXACIN IN THE TREATMENT OF DIABETIC FOOT INFECTIONS
    BEAM, TR
    GUTIERREZ, I
    POWELL, S
    HEWITT, R
    HOCKO, M
    BRACKETT, M
    CRAVER, M
    REVIEWS OF INFECTIOUS DISEASES, 1989, 11 : S1163 - S1163
  • [28] Multicenter study of the efficacy and safety of oral ciprofloxacin in the treatment of chronic suppurative otitis media in adults
    Gehanno, P
    Amsellem, A
    deRomblay, CA
    Blassin, R
    Bouznah, E
    Brunaud, A
    Car, JM
    Cambriel, J
    Chappey, C
    Chevet, J
    Cohen, B
    Cornubert, C
    Danon, J
    Darmon, J
    Donnadieu, G
    Duboux, P
    Dufour, J
    Dupuis, G
    Ebbo, D
    Fournier, JC
    Grison, J
    Hamann, C
    Huart, J
    Jacquin, JC
    Lafosse, P
    Lefranc, B
    Lelievre, G
    Levy, V
    Lhuillier, J
    Mardel, C
    Mazenc, B
    Meaux, L
    Meunier, F
    Marsac, A
    Nemni, F
    Pariente, G
    Pichelin, C
    Popot, B
    Reboul, C
    Ribatet, P
    Rousselet, JC
    Samson, J
    Timsit, C
    Tlili, N
    Quang, LT
    Trotin, G
    Tsigaridis, P
    Vie, F
    Wiatr, JB
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1997, 117 (01) : 83 - 90
  • [29] Safety and efficacy of step-down to oral outpatient treatment versus inpatient antimicrobial treatment in pediatric cancer patients with febrile neutropenia: A noninferiority multicenter randomized clinical trial
    Aviles-Robles, Martha J.
    Reyes-Lopez, Alfonso
    Otero-Mendoza, Francisco J.
    Valencia-Garin, Amilcar U.
    Penaloza-Gonzalez, Jose G.
    Rosales-Uribe, Romulo E.
    Munoz-Hernandez, Onofre
    Garduno-Espinosa, Juan
    Juarez-Villegas, Luis
    Zapata-Tarres, Marta
    PEDIATRIC BLOOD & CANCER, 2020, 67 (06)
  • [30] The efficacy and safety of cefepime or meropenem in the treatment of febrile neutropenia in patients with lung cancer. A randomized phase II study
    Fujita, Masaki
    Matsumoto, Takemasa
    Inoue, Yuuichi
    Wataya, Hiroshi
    Takayama, Koichi
    Ishida, Masayuki
    Ebi, Noriyuki
    Kishimoto, Junji
    Ichinose, Yukito
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2016, 22 (04) : 235 - 239
12345